Auna Announces Preliminary Update to Full-Year 2026 Outlook
Auna cut its preliminary full-year 2026 Adjusted EBITDA outlook to broadly stable year over year, down from prior guidance of 10-14% FX-neutral growth. The shortfall stems from a specific Colombian payor contract where an unexpectedly high incidence of advanced-stage cancer cases is creating temporary cost pressure; the company is still reviewing the contract's full-year implications.
Key figures
- Guidance
- FY2026 revenue growth in line with original guidance; Adjusted EBITDA now expected broadly stable YoY (down from prior 10-14% FX-neutral growth); capex ~4.0% of consolidated revenue
- Capex revenue pct
- 4.0%
- Prior ebitda growth guidance
- 10% to 14% FX-neutral
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.